As global sponsors seek more diverse, efficient and scalable solutions for clinical research, Latin America (LATAM) is emerging as a powerful yet underutilized region — including in ophthalmology. Join Fortrea this World Sight Day for a dynamic webinar exploring how LATAM’s unique healthcare landscape, patient population and site infrastructure can accelerate ophthalmology clinical trials and improve global trial equity.
Attendees will gain strategic insights from leading experts across the region. Tanya Richardson, Fortrea’s Therapeutic Strategy Head for Ophthalmology and Neuroscience, will be joined by renowned LATAM Principal Investigator Dr. Patricio Schlottman, representatives from IDOR (a premier site network and data lake in Brazil) and Fortrea’s Senior Clinical Research Associate Teresa Barros.
Together, the featured speakers will explore:
- LATAM’s strategic advantage in a volatile global research environment — highlighting regulatory stability, sponsor interest and the region’s growing role in diverse and inclusive trials
- The patient opportunity in LATAM, where public-private healthcare dynamics and IDOR’s data-driven access model are transforming clinical trials into viable care pathways
- What makes a site “trial-ready” in ophthalmology, with real-world lessons from Argentina and Brazil
- The power of partnership and how CRO-site collaboration is key to unlocking LATAM’s full potential
Furthermore, attendees will get a glimpse into the future of patient identification with real-world applications of AI and electronic medical records technologies — already in use across IDOR’s network.
Whether a sponsor, site or clinical operations leader, this session will equip attendees with actionable strategies to expand trial footprints and improve patient access in ophthalmology.
Register for this webinar to discover how LATAM can help you reach untapped patient populations, accelerate timelines and deliver more inclusive ophthalmology clinical trials.
Speakers
Tanya Richardson, Therapeutic Strategy Head, Ophthalmology and Neuroscience, Fortrea
Tanya Richardson has over 28 years of experience with Fortrea (formerly Labcorp, Covance and Chiltern), including monitoring, global project management, delivery director oversight and strategic planning and growth. Her clinical research experience includes a broad range of therapeutic experiences, with the last 17 years focused on ophthalmology. Tanya’s ocular experience covers front and back of the eye indications, inherited retinal and ocular rare diseases across Phase I-IV and medical device studies, as well as ocular cell and gene therapies.
Her extensive delivery background, coupled with her ocular experience, supports both internal and external stakeholders in the strategic development of a reduced burden approach, as well as an efficient and successfully executed ocular trial.
Message Presenter
Teresa Barros, Senior Clinical Research Associate, Fortrea
Teresa Barros is a Senior Clinical Research Associate at Fortrea with over five years of experience in clinical research, including both on-site and remote monitoring in Latin America. She began her career as a Clinical Study Coordinator and has since progressed through various roles within the CRA function, supporting a wide range of studies across different phases and therapeutic areas. In recent years, she has focused on ophthalmology, contributing to complex trials involving advanced therapies and medical devices. Teresa brings deep knowledge of regional regulatory environments and site operations in Argentina and neighboring countries. Her collaborative approach with investigators, attention to quality and patient-centric mindset support the successful execution of clinical trials in the region.
Message Presenter
Patricio Schlottmann, MD, Ophthalmologist and Retina Specialist, Charles Research Center
Patricio Schlottmann is an Ophthalmologist and Retina Specialist at Charles Research Center. He is also a Professor of Evidence-Based Medicine Advanced Course in Ophthalmology at the University of Buenos Aires. Professor Schlottmann completed his Research Fellowship at Moorfields Eye Hospital in London, United Kingdom. He has authored over 40 research publications in peer-reviewed international journals. He has served as the Principal Investigator for landmark retina trials, including RISE/RIDE, VIEW2, Yosemite/Rhine and for key ophthalmic therapies, namely, Ranibizumab, Faricimab, Aflibercept HD, Avacincaptad Pegol and Pegcetacoplan. He also serves as the Retina Section Editor for the Archives Spanish Society of Ophthalmology Journal, Medline Indexed and is the Head Editor for the Archives of the Argentinean Society of Ophthalmology Journal.
Message Presenter
Leandro Reis Tavares, Executive Vice President, Rede D’Or São Luiz & IDOR
Leandro Reis Tavares worked as a doctor and in healthcare management at Rede Esho and Amil Resgate Saúde. Leandro was also the Director at Laboratório Sérgio Franco and ANS. Currently, he is the Executive Vice President at Rede D’Or São Luiz.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Clinical Research Directors and Medical Directors in Ophthalmology
- Biotech and pharma companies focused on ophthalmic innovation
- Clinical Operations and R&D Leaders exploring LATAM expansion
- Biopharmaceutical Developers
- Research and Development Directors
- Clinical Development Leads
- Biomarker Discovery/Development Scientists
- Clinical Biomarker Leads
- Head of Personalized Medicine
- Translational Biomarker Scientists
What You Will Learn
Attendees will gain insight into:
- Why LATAM is becoming a strategic hotspot for ophthalmology clinical trials amid global volatility
- How patient access models and data lakes like IDOR’s are reshaping recruitment and care pathways
- What makes a site “trial-ready” in LATAM, with lessons from Argentina and Brazil
- How CRO-site partnerships and emerging tech like AI are driving smarter, faster patient identification
Xtalks Partner
Fortrea
Fortrea is a leading global clinical research organization (CRO) with over 30 years of clinical research experience, providing comprehensive Phase I-IV trial management, clinical pharmacology, and consulting services across 20+ therapeutic areas. Evolved from Covance and Labcorp, Fortrea is built for biotech and biopharma, delivering agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions in about 100 countries. We combine scientific rigor and operational excellence with innovation to help bring therapies from pipeline to patient. Together, exceptional is possible. Learn more about us at www.fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Related Webinars
Double Dippers: The Secret Lives of Serial Study Subjects
New Era of Obesity Drug Development
Patient Centricity in Neurodegenerative Diseases
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account